Multivariate and clustering analysis of metabolomic data. by Bhuripit Saraphol (20855573)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Cycle threshold values at which a specific number of dogs out of 11 dogs was able to detect SARS-CoV-2 in samples from Merida, Yucatán, México. by Víctor M. Vidal-Martínez (18707335)

Subjects:

Human <i>CTSZ</i> variants are associated with TB severity, and CTSZ is present at the host-pathogen interface within human pulmonary <i>Mtb</i> granulomas. by Rachel K. Meade (22216529)

Subjects:

Data information. by Yuxin Wei (11510974)

Subjects:

Identification and validation of <i>Ctsz</i> as the lead candidate gene underlying <i>Tip5.</i> by Rachel K. Meade (22216529)

Subjects:

IRE1 depletion induces cell cycle arrest independently of apoptosis. by Iratxe Zuazo-Gaztelu (21071939)

Subjects:

Classification of TVDI effector interactions. by Yuxin Wei (11510974)

Subjects:

Workflow of the study. by Yuxin Wei (11510974)

Subjects:

Mann–Kendall trend test grading. by Yuxin Wei (11510974)

Subjects:

Distribution of sampling sites in the study area. by Yuxin Wei (11510974)

Subjects:

Single-factor detection using Geodetector. by Yuxin Wei (11510974)

Subjects:

Study area. by Yuxin Wei (11510974)

Subjects:

Remote sensing imagery schedule. by Yuxin Wei (11510974)

Subjects:

Original raw data used to generate graphs in Figs 1–6 and S1–S6 Fig. by Iratxe Zuazo-Gaztelu (21071939)

Subjects:

IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors. by Iratxe Zuazo-Gaztelu (21071939)

Subjects: